ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Verenium and Novus International, a manufacturer of animal and human nutrition products, will jointly develop and commercialize Verenium’s enzymes for animal nutrition and health. Verenium will receive $2.5 million in license payments up front and an equal amount after commercialization of the cobranded products. Enzymes are used to help animals digest and absorb the nutrients in grains and protein meals. The products will be designed for the poultry, swine, beef, dairy, aquaculture, and pet markets. Demand for animal health enzymes is expected to reach $720 million by 2015, according to the two companies.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X